IL107184A - Heterocyclic ether compounds that enhance cognitive function - Google Patents
Heterocyclic ether compounds that enhance cognitive functionInfo
- Publication number
- IL107184A IL107184A IL10718493A IL10718493A IL107184A IL 107184 A IL107184 A IL 107184A IL 10718493 A IL10718493 A IL 10718493A IL 10718493 A IL10718493 A IL 10718493A IL 107184 A IL107184 A IL 107184A
- Authority
- IL
- Israel
- Prior art keywords
- ether compounds
- heterocyclic ether
- cognitive function
- enhance cognitive
- cholinergic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95900592A | 1992-10-09 | 1992-10-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL107184A0 IL107184A0 (en) | 1994-01-25 |
| IL107184A true IL107184A (en) | 1997-08-14 |
Family
ID=25501548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10718493A IL107184A (en) | 1992-10-09 | 1993-10-04 | Heterocyclic ether compounds that enhance cognitive function |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0663912B1 (de) |
| JP (1) | JP3098035B2 (de) |
| KR (1) | KR100311546B1 (de) |
| AT (1) | ATE210656T1 (de) |
| AU (1) | AU687017B2 (de) |
| CA (1) | CA2136075C (de) |
| DE (1) | DE69331329T2 (de) |
| DK (1) | DK0663912T3 (de) |
| ES (1) | ES2169727T3 (de) |
| IL (1) | IL107184A (de) |
| PT (1) | PT663912E (de) |
| WO (1) | WO1994008992A1 (de) |
Families Citing this family (75)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5948793A (en) * | 1992-10-09 | 1999-09-07 | Abbott Laboratories | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release |
| US5852041A (en) * | 1993-04-07 | 1998-12-22 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acethylcholine receptors |
| US5998404A (en) * | 1994-10-24 | 1999-12-07 | Eli Lilly And Company | Heterocyclic compounds and their use |
| US5605908A (en) * | 1994-10-24 | 1997-02-25 | Eli Lilly And Company | Heterocyclic compounds and their use |
| US5585388A (en) * | 1995-04-07 | 1996-12-17 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
| IL118279A (en) * | 1995-06-07 | 2006-10-05 | Abbott Lab | Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission |
| CA2237311A1 (en) * | 1995-11-13 | 1997-05-22 | Walter William Offen | Method for treating anxiety |
| US5794887A (en) | 1995-11-17 | 1998-08-18 | Komerath; Narayanan M. | Stagnation point vortex controller |
| US6979695B2 (en) | 1996-04-23 | 2005-12-27 | Targacept, Inc. | Compounds capable of activating cholinergic receptors |
| US6437138B1 (en) | 1996-06-06 | 2002-08-20 | Abbott Laboratories | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| US5629325A (en) * | 1996-06-06 | 1997-05-13 | Abbott Laboratories | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| TR199901904T2 (xx) * | 1996-12-10 | 1999-10-21 | Abbott Laboratories | 3-piridil enantiyomerleri ve bunlar�n analjezik olarak kullan�lmas�. |
| US6133253A (en) * | 1996-12-10 | 2000-10-17 | Abbott Laboratories | 3-Pyridyl enantiomers and their use as analgesics |
| CA2287223A1 (en) * | 1997-04-26 | 1998-11-05 | Tomohiro Toyoda | 2-azabicyclo compounds |
| US6525065B1 (en) | 1997-06-30 | 2003-02-25 | Targacept, Inc. | Pharmaceutical compositions and methods for effecting dopamine release |
| US6624173B1 (en) | 1997-06-30 | 2003-09-23 | Targacept, Inc. | Pharmaceutical compositions for treating and/or preventing CNS disorders |
| US7214686B2 (en) | 1997-06-30 | 2007-05-08 | Targacept, Inc. | Pharmaceutical compositions and methods for effecting dopamine release |
| CA2306477A1 (en) * | 1997-11-05 | 1999-05-20 | Neurosearch A/S | Azaring-ether derivatives and their use as nicotinic ach receptor modulators |
| DK1047690T3 (da) * | 1997-12-19 | 2004-07-05 | Abbott Lab | Heterocykliske ether- og thioetherforbindelser, som er anvendelige til regulering af kemisk, synaptisk overförsel |
| EP1068186A2 (de) | 1998-04-02 | 2001-01-17 | Targacept, Inc. | 3-pyridylalkoxyamine oder aryloxyalkylamine derivate als cholinergische agonisten |
| CA2317567A1 (en) * | 1998-04-02 | 1999-10-14 | R.J. Reynolds Tobacco Company | Pharmaceutical compositions and methods for use |
| US6218383B1 (en) | 1998-08-07 | 2001-04-17 | Targacept, Inc. | Pharmaceutical compositions for the prevention and treatment of central nervous system disorders |
| US6432975B1 (en) | 1998-12-11 | 2002-08-13 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
| US6953855B2 (en) | 1998-12-11 | 2005-10-11 | Targacept, Inc. | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| US20010031771A1 (en) | 1999-05-24 | 2001-10-18 | Gary Maurice Dull | Pharmaceutical compositions and methods for use |
| US6544976B1 (en) | 1999-07-09 | 2003-04-08 | Ortho-Mcneil Pharmaceutical, Inc. | Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods |
| CA2381252A1 (en) * | 1999-09-14 | 2001-03-22 | Abbott Laboratories | 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission |
| US6890935B2 (en) | 1999-11-01 | 2005-05-10 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
| US6812314B2 (en) | 2001-10-17 | 2004-11-02 | University Of Florida | Thermally responsive polymer materials and uses thereof |
| AU2002360598B2 (en) | 2001-12-14 | 2008-02-14 | Medical College Of Georgia Research Institute, Inc. | Methods and compositions for treatment of central nervous system disorders |
| EA009789B1 (ru) | 2002-07-05 | 2008-04-28 | Таргасепт, Инк. | N-арилдиазаспирациклические соединения и способы их получения и применения |
| AU2003254016A1 (en) | 2002-07-19 | 2004-02-09 | Catholic Healthcare West | Methods and compositions relating to chimeric nicotinic receptor subunits |
| GB0220581D0 (en) | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
| US7098331B2 (en) | 2003-03-05 | 2006-08-29 | Targacept, Inc. | Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| EP1678172B1 (de) | 2003-10-15 | 2009-12-09 | Targacept, Inc. | Azabicyclische verbindungen zur linderung von schmerzen und zur behandlung von erkrankungen des zentralen nervensystems |
| US20070191815A1 (en) | 2004-09-13 | 2007-08-16 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery |
| PE20060437A1 (es) | 2004-06-18 | 2006-06-08 | Novartis Ag | COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR |
| GB0415746D0 (en) | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
| CN101044134A (zh) | 2004-09-20 | 2007-09-26 | 塔加西普特公司 | 具有烟碱性胆碱能受体活性的氮杂螺烯和氮杂螺烷化合物 |
| UA88792C2 (ru) | 2004-11-10 | 2009-11-25 | Таргасепт, Інк. | Гидроксибензоатные соли метаникотиновых соединений |
| US7459469B2 (en) | 2004-11-10 | 2008-12-02 | Targacept, Inc. | Hydroxybenzoate salts of metanicotine compounds |
| CA2618700A1 (en) | 2005-08-22 | 2007-03-01 | Targacept, Inc. | Heteroaryl-substituted diazatricycloalkanes, methods for its preparation and use thereof |
| GB0521508D0 (en) | 2005-10-21 | 2005-11-30 | Novartis Ag | Organic compounds |
| GB0525672D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
| GB0525673D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
| TWI389889B (zh) | 2006-05-09 | 2013-03-21 | Targacept Inc | （２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型 |
| EP2021325A2 (de) | 2006-05-09 | 2009-02-11 | AstraZeneca AB | Salzformen von (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amin |
| TWI454262B (zh) | 2006-11-02 | 2014-10-01 | Targacept Inc | 菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺 |
| BRPI0719130A2 (pt) * | 2006-11-29 | 2013-12-17 | Basf Se | Métodos para combater peste, para proteger plantas em crescimento de ataque ou infestação por pestes e para proteger semente, semente, uso de um composto, composição pesticida, composto, e, misturas pesticidas sinergísticas. |
| WO2008091588A1 (en) | 2007-01-22 | 2008-07-31 | Targacept, Inc. | Intranasal, buccal, and sublingual administration of metanicotine analogs |
| TW200845977A (en) | 2007-03-30 | 2008-12-01 | Targacept Inc | Sub-type selective azabicycloalkane derivatives |
| ES2521494T3 (es) | 2007-04-02 | 2014-11-12 | Parkinson's Institute | Métodos y composiciones para la reducción de los efectos secundarios de tratamientos terapéuticos |
| SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
| KR101565469B1 (ko) | 2007-10-01 | 2015-11-03 | 코멘티스, 인코포레이티드 | 알츠하이머병의 치료를 위한 알파 7 니코틴 아세틸콜린 수용체 리간드로서 퀴누클리딘-4-일메틸 1ｈ-인돌-3-카르복실레이트 유도체 |
| KR20110091501A (ko) * | 2008-10-14 | 2011-08-11 | 싸이코제닉스 아이엔씨. | 니코틴성 아세틸콜린 수용체 리간드 및 이들의 용도 |
| CN102232070A (zh) | 2008-12-01 | 2011-11-02 | 塔加西普特公司 | (r)-5-((e)-2-(吡咯烷-3-基乙烯基)嘧啶的合成和新的盐形式 |
| TW201024283A (en) | 2008-12-01 | 2010-07-01 | Targacept Inc | Synthesis and novel salt forms of (R)-3-((E)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine |
| US9145396B2 (en) | 2008-12-01 | 2015-09-29 | Targacept, Inc. | Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine |
| WO2010080757A2 (en) | 2009-01-07 | 2010-07-15 | Astrazeneca Ab | Combinations with an alpha-4beta-2 nicotinic agonist |
| TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
| EP2509982A1 (de) | 2009-12-07 | 2012-10-17 | Targacept, Inc. | 3,6-diazabicyclo[3.1.1]heptane als neuronale nikotinische acetylcholinreceptorliganden |
| CN103180277A (zh) | 2010-05-20 | 2013-06-26 | 塔格塞普特股份有限公司 | 制备芳基取代的烯属胺的新方法 |
| NZ603966A (en) | 2010-05-27 | 2015-03-27 | Targacept Inc | Nicotinic receptor non-competitive antagonists |
| WO2012125518A1 (en) | 2011-03-14 | 2012-09-20 | Targacept, Inc. | Salt forms of 3 - cyclopropylcarbonyl - 3, 6 - diazabicyclo [3.1.1] heptane |
| WO2012129262A1 (en) | 2011-03-23 | 2012-09-27 | Targacept, Inc. | Treatment of attention deficit/hyperactivity disease |
| TW201311698A (zh) | 2011-08-22 | 2013-03-16 | Targacept Inc | 作為神經元菸鹼乙醯膽鹼受體配位體之１，４－二氮雜雙環［３．２．２］壬烷 |
| WO2013071097A1 (en) | 2011-11-11 | 2013-05-16 | Georgetown University | 2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof |
| US20170166561A1 (en) | 2014-07-11 | 2017-06-15 | Alpharmagen, Llc | Quinuclidine compounds for modulating alpha7-nicotinic acetylcholine receptor activity |
| WO2016123406A1 (en) | 2015-01-28 | 2016-08-04 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
| US9724340B2 (en) | 2015-07-31 | 2017-08-08 | Attenua, Inc. | Antitussive compositions and methods |
| CN105418477B (zh) * | 2015-12-22 | 2018-12-21 | 爱斯特（成都）生物制药股份有限公司 | 降低雷迪帕韦中间体中非对映异构体杂质含量的方法 |
| WO2018129304A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
| CA3101966A1 (en) | 2018-05-29 | 2019-12-05 | Morningside Venture Investments Limited | Drug delivery methods and systems |
| US12397141B2 (en) | 2018-11-16 | 2025-08-26 | Morningside Venture Investments Limited | Thermally regulated transdermal drug delivery system |
| JP2023532848A (ja) * | 2020-06-24 | 2023-08-01 | フィリップ・モーリス・プロダクツ・ソシエテ・アノニム | 寄生虫防除のための組成物および方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA848275B (en) * | 1983-12-28 | 1985-08-28 | Degussa | New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring |
| CA1307790C (en) * | 1987-08-04 | 1992-09-22 | Ian Anthony Cliffe | Ethers |
| YU84791A (sh) * | 1990-05-19 | 1994-06-10 | Boehringer Ingelheim Kg. | Biciklicni 1-aza-cikloalkalni |
-
1993
- 1993-10-04 IL IL10718493A patent/IL107184A/xx not_active IP Right Cessation
- 1993-10-08 AT AT93923826T patent/ATE210656T1/de active
- 1993-10-08 ES ES93923826T patent/ES2169727T3/es not_active Expired - Lifetime
- 1993-10-08 DE DE69331329T patent/DE69331329T2/de not_active Expired - Lifetime
- 1993-10-08 KR KR1019940704340A patent/KR100311546B1/ko not_active Expired - Fee Related
- 1993-10-08 WO PCT/US1993/009662 patent/WO1994008992A1/en not_active Ceased
- 1993-10-08 CA CA002136075A patent/CA2136075C/en not_active Expired - Fee Related
- 1993-10-08 AU AU53557/94A patent/AU687017B2/en not_active Ceased
- 1993-10-08 JP JP06510167A patent/JP3098035B2/ja not_active Expired - Fee Related
- 1993-10-08 DK DK93923826T patent/DK0663912T3/da active
- 1993-10-08 EP EP93923826A patent/EP0663912B1/de not_active Expired - Lifetime
- 1993-10-08 PT PT93923826T patent/PT663912E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69331329T2 (de) | 2002-08-08 |
| ES2169727T3 (es) | 2002-07-16 |
| DE69331329D1 (de) | 2002-01-24 |
| EP0663912A1 (de) | 1995-07-26 |
| AU687017B2 (en) | 1998-02-19 |
| DK0663912T3 (da) | 2002-04-15 |
| EP0663912B1 (de) | 2001-12-12 |
| CA2136075C (en) | 2004-12-14 |
| JP3098035B2 (ja) | 2000-10-10 |
| ATE210656T1 (de) | 2001-12-15 |
| IL107184A0 (en) | 1994-01-25 |
| PT663912E (pt) | 2002-06-28 |
| AU5355794A (en) | 1994-05-09 |
| WO1994008992A1 (en) | 1994-04-28 |
| KR100311546B1 (ko) | 2005-12-06 |
| EP0663912A4 (de) | 1995-02-17 |
| JPH08502481A (ja) | 1996-03-19 |
| CA2136075A1 (en) | 1994-04-28 |
| KR950701920A (ko) | 1995-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL107184A0 (en) | Heterocyclic ether compounds that enhance cognitive function | |
| AP1852A (en) | '3-Azabicyclo{3.1.0] hexane derivatives as opiate receptors ligands. | |
| TW264477B (de) | ||
| NZ227131A (en) | Compositions for improving cognitive function by administering 1,2-oxazole derivatives | |
| NZ330023A (en) | Fused pyrrolecarboxanilides and their use as a GABA brain receptor ligands | |
| FI931888A0 (fi) | Kramploesande cykliska fruktopyranossulfiter -och sulfater | |
| HUT59109A (en) | Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same | |
| DE69730229D1 (de) | 3-pyridyloxymethyl heterocyclische ether verbindungen für die kontrolle chemischer synaptischer übertragung | |
| HUT73437A (en) | Novel pyrrolocarbazoles | |
| JO1704B1 (en) | New potent compounds | |
| HU9200656D0 (en) | Method for producing morpholinyl derivatives of doxorubicine and pharmaceutical preparatives containing said compounds | |
| AP2000001846A0 (en) | Triazine compounds for treatment of CNS disorders. | |
| AU1054200A (en) | Neurological disorders | |
| FI962976L (fi) | Viherkaihin hoitoon tarkoitettuja koostumuksia, jotka sisältävät beta-salpaajaa | |
| MY125674A (en) | Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis | |
| DE3475073D1 (en) | Azahomoerythromycin b derivatives and intermediates thereof | |
| PT1049672E (pt) | Derivados de azetidinocarboxamida para o tratamento de disturbios do snc | |
| AU2178199A (en) | Azetidinecarboxamide derivatives for the treatment of cns disorders | |
| EP0469782A3 (en) | Treatment of cataract with prostacyclin compounds | |
| PT1049670E (pt) | Derivados de azetidinocarboxamida para o tratamento de perturbacoes do snc | |
| GR3023827T3 (en) | Indole-sulfonamides as antitumor agents. | |
| ZA81472B (en) | N-methyl-n-silyl-carbamates and their use for combating pests | |
| AP9200347A0 (en) | Fungicides. | |
| MY130771A (en) | 3-azabicyclo [3.1.0] hexane derivatives useful in therapy. | |
| MY104630A (en) | 4(1h) ouinoline derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |